SHMT2 and malignant colon neoplasm: Recent studies demonstrated that SHMT2 is necessary for sustaining mitochondrial translation in the Jurket human leukemic (Minton et al, 2018) and HCT116 human colon cancer (Morscher et al, 2018) cells.